Form 4: CRH Executive Reports Share Vesting and RSU Grants
Insider Transaction Report
CRH's President of Americas Division, Nathan Creech, reported significant share acquisitions from vested awards and tax-related dispositions, alongside new RSU grants.
Summary
- Nathan Creech, President, Americas Division of CRH Public Ltd Co, reported multiple transactions involving CRH Ordinary Shares and derivative securities.
- Acquired 64,171 Ordinary Shares on February 23, 2026, from the vesting and release of 2023 Performance Share Plan awards, including 4,386 dividend equivalents.
- Acquired an additional 9,863 Ordinary Shares on February 23, 2026, from the vesting and release of a time-based conditional award under the 2014 Deferred Share Bonus Plan, including 675 dividend equivalents.
- Disposed of 29,134 Ordinary Shares on February 23, 2026, at a price of $121.49 per share, to cover applicable tax liabilities related to the aforementioned awards.
- Acquired 11,603 Restricted Share Units (RSUs) on February 23, 2026, under the CRH plc Equity Incentive Plan, with 1/3 vesting annually in February 2027, 2028, and 2029.
- Following these transactions, direct beneficial ownership of Ordinary Shares is 144,796.
- Beneficial ownership of Deferred Shares is 12,588 and Restricted Share Units is 59,906.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive, routine filing. The vesting of awards indicates performance achievement and continued executive alignment, while the tax-related disposition is a standard consequence of such events.
Positives
- Vesting of 64,171 Ordinary Shares from performance-based awards, indicating achievement of pre-established goals.
- Vesting of 9,863 Ordinary Shares from time-based deferred share bonus awards.
- Grant of 11,603 new Restricted Share Units, aligning executive incentives with future company performance.
Negatives
- Disposition of 29,134 Ordinary Shares to cover tax liabilities, reducing direct shareholding.
Future Outlook
The future outlook includes the scheduled vesting of the newly granted Restricted Share Units, with one-third vesting annually in February 2027, 2028, and 2029. Dividend equivalents will apply to these awards and will be reported at the time of vesting.
Industry Context
StockSavvy.ai notes that these transactions are routine executive compensation events, reflecting the vesting of previously granted performance and time-based awards, as well as new equity grants designed to align executive interests with long-term shareholder value. Such filings are common across publicly traded companies as part of their executive incentive programs.
Stakeholder Impact
- Shareholders: These transactions demonstrate the ongoing operation of CRH's executive compensation plans, aligning management's interests with shareholder value through equity ownership. The vesting of performance awards suggests the company met certain goals.
- Employees: Reflects the company's established equity incentive programs for key executives.
Next Steps
- Future vesting of Restricted Share Units in February 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 2023 | Year of grant for Performance Share Plan awards that vested on February 23, 2026. |
| 02/23/2026 | Date of all reported share acquisitions, dispositions, and RSU grants. |
| 02/25/2026 | Date the Form 4 was signed by the Attorney-in-Fact. |
| 02/2027 | First vesting date for 1/3 of the newly granted Restricted Share Units. |
| 02/2028 | Second vesting date for 1/3 of the newly granted Restricted Share Units. |
| 02/2029 | Third and final vesting date for 1/3 of the newly granted Restricted Share Units. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation, including the vesting of performance and time-based awards and a new RSU grant, alongside a tax-related share disposition. These events are standard and do not provide new fundamental information that would significantly alter the investment thesis for CRH. Therefore, a 'hold' recommendation is appropriate as the filing does not present a catalyst for a change in investment strategy.
Keywords
CRH, Insider Transaction, Form 4, Share Vesting, Restricted Share Units, Executive Compensation, Performance Shares, Deferred Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.